BeiGene to Announce First Quarter 2025 Financial Results on May 7 | ONC Stock News

Author's Avatar
Apr 17, 2025
Article's Main Image
  • BeiGene (ONC, Financial) to report Q1 2025 financial results on May 7, 2025.
  • Company plans to rebrand as BeOne Medicines.
  • A live management webcast will follow the financial release at 8:00 a.m. ET.

BeiGene, Ltd. (NASDAQ: ONC), a global oncology company, has announced it will release its first quarter 2025 financial results on Wednesday, May 7, 2025, before market open. The company, which plans to change its name to BeOne Medicines, will provide insights into its financial performance via a live management webcast scheduled for 8:00 a.m. ET on the same day.

Investors and interested parties can access the live webcast through the investors section of BeiGene's website. It is advised to register at least 15 minutes before the scheduled start time to ensure timely connection. The recording of the webcast will be archived on the company's website for future reference.

BeiGene is known for its commitment to developing innovative and accessible cancer treatments globally, with a growing team of over 11,000 employees worldwide. The company's strategic direction includes expediting the development of a diverse pipeline of novel therapeutics through internal capabilities and collaborations.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.